Can your LNP manufacturing platform cope with the pace of the mRNA revolution?
Pharmaceutical Technology
APRIL 27, 2023
GlobalData pharmaceutical analysts project that RNA-based gene therapies for oncology will grow from zero in 2022 to $4.6 Makowiecki says the same benefits apply to the development and manufacture of RNA-LNPs as in other biopharmaceutical manufacturing, while accommodating for their unique characteristics. billion by 2028.
Let's personalize your content